Interactor compound |
Clinical Study |
AUC ratio |
Cmax ratio |
CL ratio |
Talinolol Quantification |
Ref. |
R-Verapamil |
Healthy volunteers were orally co-administered with talinolol (50 mg) and R-verapamil (120 mg) |
AUC0-24: 0.76 |
0.66 |
CLR ≈ 1.0 |
HPLC |
[195] |
Erythromycin |
Healthy male volunteer co-administered orally with talinolol (50 mg) and erythromycin (2 g) |
AUC0-∞ increased 52% |
Cmax increased 26% |
CL/F ≈1.0 |
HPLC |
[196] |
Carbamazepine |
Healthy volunteers pre-treated with oral CBZ (600 mg id): for 18 days and repeated oral administration of talinolol |
0.86 |
- |
CL/F: 1.15 |
- |
[197] |
for 18 days after infusion of talinolol (30 mg /30 min) |
1.03 |
- |
CL/F: 0.99 |
TPGS |
Intra-duodenal perfusion on healthy male volunteers |
AUC0-∞ : 1.39
AUC0-6: 2.11 |
2.00 |
- |
LC-MS/MS |
[192] |
Poloxamer 188 |
AUC0-∞ : 0.91
AUC0-6: 0.99 |
1.13 |
- |
GFJ |
Healthy volunteers pre-treated with GFJ (900 mL; id) for 6 days and orally administered with talinolol (50 mg) |
AUC decreased 56% |
Cmax decreased 57% |
- |
HPLC |
[195] |
Curcumin |
Healthy volunteers pre-treated with curcumin (300 mg) orally administered for 6 days. |
AUC0-∞ : 0.67 |
0.72 |
CL/F: 1.54 |
HPLC-ESI-MS/MS |
[198] |
SJW |
Healthy volunteers co-administered with single oral dose of SJW (900 mg) and oral talinolol (50 mg) |
AUC0-24 : 0.68
AUC0-∞: 0.69 |
0.79 |
CL/F: 1.93
CLR: 0.83 |
HPLC |
[189] |
and IV talinolol (30 mg / 30 min infusion) |
AUC0-24 : 0.98
AUC0-∞: 0.93 |
- |
CLR: 0.87
CLNR: 1.35 |
GBE |
Healthy male volunteers co-administered with single oral dose of GBE (120 mg) and talinolol (100 mg) |
AUC0-24 : 0.90
AUC0-∞: 0.91 |
0.88 |
- |
HPLC-UV |
[199] |
Healthy male volunteers pre-treated with GBE (120 mg; tid) orally administered for 14 days |
AUC0-24 : 1.26
AUC0-∞: 1.22 |
1.36 |
- |
Silymarin |
Healthy volunteers pre-treated with silymarin (140 mg; tid) for 14 days |
AUC0-36 increased 36.2% |
- |
Decreased 23.1% |
HPLC-MS |
[200] |
Duloxetine |
Healthy volunteers orally administered with duloxetine (30 mg) and talinolol (50 mg) |
AUC0-60 : 0.87 |
0.87 |
- |
HPLC-ESI-MS/MS |
[102] |